Pleasant Valley, MO, United States of America

Jonathan M White


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Jonathan M. White

Introduction

Jonathan M. White, hailing from Pleasant Valley, MO, is a notable figure in the field of pharmacological innovations. He holds a singular patent that showcases his contribution to medical science, particularly in the treatment of cancer. His dedication to advancing healthcare through innovative solutions is evident in his work.

Latest Patents

White's patent revolves around a STAT3 inhibitor formulation, specifically a salt created from the STAT3 inhibitor known as 2-hydroxy-4-[[2-[[(4-methylphenyl)sulfonyl]oxy]acetyl]amino] benzoic acid combined with 2-amino-2-(hydroxymethyl)-1,3-propanediol. This unique salt is noted for its water solubility and stability over extended periods, making it a promising candidate for pharmaceutical applications. Furthermore, the patent outlines formulations and methodologies for administering this salt to prevent and treat various cancers, including breast cancer.

Career Highlights

Throughout his career, Jonathan M. White has collaborated with significant organizations, contributing his expertise to advance healthcare solutions. Notably, he has worked with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, and Glg Pharma, LLC. His work in these institutions has been vital in fostering innovation and improving treatment options in the medical field.

Collaborations

White has collaborated with esteemed colleagues such as Robert H. Shoemaker and Michael W. Lovell. Their collective expertise underscores the importance of teamwork in the realm of medical research and development, facilitating breakthroughs that have the potential to change lives.

Conclusion

Jonathan M. White exemplifies the spirit of innovation within the pharmaceutical sector. Through his patent on the STAT3 inhibitor formulation, he has made significant strides in cancer treatment methodologies. His partnerships with prominent organizations and colleagues further highlight the collaborative nature of scientific progress, demonstrating that innovation often results from shared knowledge and expertise.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…